Showing results (1-10 of 51) with videos related to

Sort By:
Pageof 6
Folia Histochemica Et Cytobiologica|December 31, 2005
Proliferative senescence in hematopoietic stem cells during ex-vivo expansionWanda Piacibello, Loretta Gammaitoni, Ymera Pignochino
Molecules (Basel, Switzerland)|February 21, 2020
Phage Display-Based Nanotechnology Applications in Cancer ImmunotherapyMartina Goracci, Ymera Pignochino, Serena Marchiò
International Journal of Molecular Sciences|March 29, 2023
Exosome-Based Liquid Biopsy Approaches in Bone and Soft Tissue Sarcomas: Review of the Literature, Prospectives, and Hopes for Clinical ApplicationChiara Agnoletto, Ymera Pignochino, Chiara Caruso, et al.
International Journal of Molecular Sciences|August 29, 2024
Nanoparticles-Delivered Circular RNA Strategy as a Novel Antitumor ApproachLuisa Racca, Elisabetta Liuzzi, Simona Comparato, et al.
Cell Communication and Signaling : CCS|September 9, 2024
Targeting the EphA2 pathway: could it be the way for bone sarcomas?Giorgia Giordano, Cristina Tucciarello, Alessandra Merlini, et al.
Pharmacology & Therapeutics|November 23, 2019
Delving into PARP inhibition from bench to bedside and backGiovanni Grignani, Alessandra Merlini, Dario Sangiolo, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 10, 2006
Tumor cell purging by ex vivo expansion of hemopoietic stem cells from breast cancer patients combined with targeting ErbB receptorsFrancesco Leone, Giuliana Cavalloni, Monica Gunetti, et al.
Oncology Research|December 7, 2013
Prolonged disease stability with trabectedin in a heavily pretreated elderly patient with metastatic leiomyosarcoma of the thigh and renal failure: a case report and review of the literatureDanilo Galizia, Erica Palesandro, Anna Maria Nuzzo, et al.
Translational Oncology|June 18, 2014
Activation of oncogenic pathways in idiopathic pulmonary fibrosisGiulia M Stella, Simona Inghilleri, Ymera Pignochino, et al.
Cell Death & Disease|June 19, 2019
Exosomes from CD99-deprived Ewing sarcoma cells reverse tumor malignancy by inhibiting cell migration and promoting neural differentiationAlessandra De Feo, Marika Sciandra, Manuela Ferracin, et al.
Pageof 6